NextPlat Q2 Revenue Jumps 21% Sequentially, Net Loss Narrows to $144K
NXPL sits 99% above its 52-week low of $3.375.
Summary
NextPlat reported Q2 2026 revenue of $11.9M, up 21% sequentially from Q1's $9.9M, with net loss slashed 87% to $144,000 and gross margin hitting a record 40%. The improvement was driven by a 136% YoY surge in contracted pharmacy revenue to $2.2M, fueled by 340B contracts and medication fulfillment services, while e-commerce revenue rose 27% sequentially to $4.1M on strong satellite/IoT demand. This follows the July mid-year update that flagged a faster path to profitability, and the company's recent Scott's Pharmacy acquisition adds scale in Florida. The results mark a clear inflection from Q1's 29% revenue decline and going-concern warning, though the company remains small with a market cap around $18M. Watch for continued 340B contract onboarding and whether the margin gains hold as the company pursues selective acquisitions.
At the time of this announcement, NXPL was trading at $6.71 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $18.2M. The 52-week trading range was $3.38 to $11.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.